Top compounds associated with response to MARCH10

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Gefitinib	CTRPv2	pan-cancer	AAC	0.0087	0.8
mRNA	alisertib	CTRPv2	pan-cancer	AAC	-0.0075	0.8
mRNA	Tamoxifen	GDSC1000	pan-cancer	AAC	-0.0079	0.8
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.0073	0.8
mRNA	Irinotecan	gCSI	pan-cancer	AAC	0.013	0.8
mRNA	KIN001-102	GDSC1000	pan-cancer	AAC	-0.0068	0.8
mRNA	ruxolitinib	CTRPv2	pan-cancer	AAC	-0.0079	0.8
mRNA	SB 216763	GDSC1000	pan-cancer	AAC	0.0085	0.8
mRNA	crizotinib:PLX-4032 (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.0078	0.8
mRNA	GSK-1904529A	GDSC1000	pan-cancer	AAC	0.0075	0.8

Download CSV